Life Sciences Summit to Showcase Investment Trends and Entrepreneurial Insights in Utah

The upcoming 2025 Entrepreneur & Investor Life Sciences Summit, organized by BioUtah and the University of Utah's Technology Licensing Office, promises to deliver comprehensive insights into the dynamic life sciences landscape. Featuring prominent keynote speakers and expert panels, the event will explore critical aspects of investment, entrepreneurship, and technological innovation.

Keynote speakers Monica DiCenso from J.P. Morgan Private Bank and Earl 'Eb' Bright from Stanford BioDesign will headline the March 13 event in Salt Lake City. DiCenso, a managing director overseeing global investment opportunities, will share perspectives on the life sciences investment environment, while Bright will discuss entrepreneurial challenges and opportunities.

The summit will feature multiple high-profile panels, including a discussion on 'Building a Life Sciences Company' with CEOs from innovative Utah-based organizations such as Recursion, Nusano, Culmination Bio, and Owlet Baby Care. Another panel will focus on venture capital's role in driving life sciences growth, featuring investors from Epic Ventures, Stephens, Cross-Border Impact Ventures, and J.P. Morgan Life Sciences Private Capital.

A distinctive feature of the event is its Pitch Competition, where emerging life sciences companies will present their innovations across medical devices, diagnostics, pharmaceuticals, therapeutics, and digital health categories. Winners will receive cash prizes and recognition, providing a platform for potentially transformative technologies to gain visibility.

The summit underscores Utah's increasingly significant role in the life sciences ecosystem. By bringing together investors, entrepreneurs, and industry leaders, the event aims to foster networking, knowledge exchange, and potential collaborations that could drive future medical and technological advancements.

Specialized track sessions will offer attendees deeper insights into funding sources, entrepreneurial experiences, and legal considerations, making the summit a comprehensive professional development opportunity for life sciences professionals.